Moreover, they presented a case study of an MM patient diagnosed with a BRAF V600E mutation and experiencing a relapse of myeloma accompanied by widespread extramedullary involvement; this patient exhibited a rapid and sustained positive response to low doses of vemurafenib. Here, BRAF is linked to Miyoshi myopathy.